Free Trial
OTCMKTS:BABYF

Else Nutrn 4/1/2024 Earnings Report

Else Nutrn logo
$0.02 +0.00 (+4.76%)
As of 07/16/2025 03:58 PM Eastern

Else Nutrn EPS Results

Actual EPS
-$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Else Nutrn Revenue Results

Actual Revenue
$1.74 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Else Nutrn Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Else Nutrn Earnings Headlines

[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Else Nutrition Holdings Inc. (BABYF) - Yahoo Finance
Else Nutrition Holdings Inc. (BABY.TO) - Yahoo Finance
See More Else Nutrn Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Else Nutrn? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Else Nutrn and other key companies, straight to your email.

About Else Nutrn

Else Nutrn (OTCMKTS:BABYF) (OTCMKTS:BABYF) is a plant-based nutrition company focused on developing and marketing non-dairy infant and toddler food products. The company’s mission centers on providing allergen-friendly nutrition solutions that are free of soy, lactose, and nuts, catering to growing consumer demand for clean-label, sustainable alternatives to traditional dairy-based options. Through proprietary formulations, Else Nutrn aims to deliver balanced macronutrient and micronutrient profiles suited to the dietary needs of infants and young children.

The company’s product portfolio includes a range of stage-specific nutritional blends, including infant formula for newborns (Stage 1), follow-on formula for older babies (Stage 2), and complementary toddler drinks. These products are fortified with essential vitamins and minerals such as iron, calcium, vitamin D and B12, and incorporate plant-derived proteins sourced from fava beans and other legumes. Packaging and powder formats are designed for ease of use, enabling parents to prepare servings quickly while ensuring product stability and shelf life without refrigeration.

Else Nutrn markets its products primarily in North America and Israel, leveraging both e-commerce channels and brick-and-mortar retail partnerships. In the United States and Canada, the company has established distribution agreements with select natural food retailers, specialty baby stores and online marketplaces. Else Nutrn continues to explore expansion opportunities into additional international markets by securing regulatory approvals and forging alliances with regional distributors and healthcare practitioners to bolster brand visibility and consumer trust.

Founded in 2017 by co-founders Ehud Yanai and Nimrod Noy, Else Nutrn has built its operations around a network of research collaborators specializing in pediatric nutrition and food science. The executive team is led by CEO Ehud Yanai, whose background in consumer packaged goods and startup growth strategies guides the company’s commercial and product development efforts. With a management roster that includes seasoned professionals in regulatory affairs, supply chain management and quality assurance, Else Nutrn remains committed to innovation, safety and transparency in the infant nutrition sector.

View Else Nutrn Profile

More Earnings Resources from MarketBeat